Inhibition of Tolbutamide Elimination by Cimetidine but not Ranitidine
This study was designed to compare the effects of equivalent therapeutic doses of two H2 antagonists, cimetidine and ranitidine, on tolbutamide pharmacokinetics. Twelve healthy men were given a 1‐g oral dose of tolbutamide on three occasions. Subjects were randomly assigned to three treatments in a...
Gespeichert in:
Veröffentlicht in: | Journal of clinical pharmacology 1986-05, Vol.26 (5), p.372-377 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 377 |
---|---|
container_issue | 5 |
container_start_page | 372 |
container_title | Journal of clinical pharmacology |
container_volume | 26 |
creator | Cate, Emily W. Rogers, John F. Powell, J. Robert |
description | This study was designed to compare the effects of equivalent therapeutic doses of two H2 antagonists, cimetidine and ranitidine, on tolbutamide pharmacokinetics. Twelve healthy men were given a 1‐g oral dose of tolbutamide on three occasions. Subjects were randomly assigned to three treatments in a crossover fashion: cimetidine 1,200 mg/d, ranitidine 300 mg/d, and placebo. Cimetidine significantly increased the tolbutamide area under the plasma concentration‐time curve by 20% (range, −5% to 42%), increased the elimination half‐life by 17%, and decreased the carboxytolbutamide:tolbutamide plasma ratio from 0.042 to 0.036. Ranitidine did not significantly alter tolbutamide pharmacokinetics. |
doi_str_mv | 10.1002/j.1552-4604.1986.tb03540.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76801162</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76801162</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4380-381b2a260bf426f7db46eccdcbd7a1e650d0b74e153b930e9daf16018f2073fb3</originalsourceid><addsrcrecordid>eNqVkM1O3DAUhS1EBVPaR0CKEGKX9N7YsRNWoIi_CihUIJaWndjCQ36GOKPOvH2TJpp9V7bu-e6x9RFyghAhQPxjGWGSxCHjwCLMUh71GmjCINrskcUu2icLgAzDWAAckq_eLwGQswQPyAEdZjzDBbm-a96ddr1rm6C1wUtb6XWvalea4KpytWvUv0hvg9zVpnela0wwIEHT9sFv1bhp9I18sary5vt8HpHX66uX_Da8_3Vzl1_ehwWjKYQ0RR2rmIO2LOZWlJpxUxRloUuh0PAEStCCGUyoziiYrFQWOWBqYxDUanpEzqbeVdd-ro3vZe18YapKNaZdeyl4Cog8HsDzCSy61vvOWLnqXK26rUSQo0S5lKMpOZqSo0Q5S5SbYfl4fmWta1PuVmdrQ34658oXqrKdagrnd5hI05QKNmAXE_bHVWb7Hx-QP_On2_E6VIRThfO92ewqVPchuaAikW-PN5I-CED6nEukfwFWF52N</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76801162</pqid></control><display><type>article</type><title>Inhibition of Tolbutamide Elimination by Cimetidine but not Ranitidine</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Cate, Emily W. ; Rogers, John F. ; Powell, J. Robert</creator><creatorcontrib>Cate, Emily W. ; Rogers, John F. ; Powell, J. Robert</creatorcontrib><description>This study was designed to compare the effects of equivalent therapeutic doses of two H2 antagonists, cimetidine and ranitidine, on tolbutamide pharmacokinetics. Twelve healthy men were given a 1‐g oral dose of tolbutamide on three occasions. Subjects were randomly assigned to three treatments in a crossover fashion: cimetidine 1,200 mg/d, ranitidine 300 mg/d, and placebo. Cimetidine significantly increased the tolbutamide area under the plasma concentration‐time curve by 20% (range, −5% to 42%), increased the elimination half‐life by 17%, and decreased the carboxytolbutamide:tolbutamide plasma ratio from 0.042 to 0.036. Ranitidine did not significantly alter tolbutamide pharmacokinetics.</description><identifier>ISSN: 0091-2700</identifier><identifier>EISSN: 1552-4604</identifier><identifier>DOI: 10.1002/j.1552-4604.1986.tb03540.x</identifier><identifier>PMID: 3700691</identifier><identifier>CODEN: JCPCBR</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; Biological and medical sciences ; Blood Glucose - analysis ; Chromatography, High Pressure Liquid ; Cimetidine - pharmacology ; Double-Blind Method ; Half-Life ; Histamine and antagonists. Allergy ; Humans ; Male ; Medical sciences ; Pharmacology. Drug treatments ; Ranitidine - pharmacology ; Tolbutamide - analogs & derivatives ; Tolbutamide - blood ; Tolbutamide - metabolism</subject><ispartof>Journal of clinical pharmacology, 1986-05, Vol.26 (5), p.372-377</ispartof><rights>1986 American College of Clinical Pharmacology</rights><rights>1987 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4380-381b2a260bf426f7db46eccdcbd7a1e650d0b74e153b930e9daf16018f2073fb3</citedby><cites>FETCH-LOGICAL-c4380-381b2a260bf426f7db46eccdcbd7a1e650d0b74e153b930e9daf16018f2073fb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fj.1552-4604.1986.tb03540.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fj.1552-4604.1986.tb03540.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=7888374$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3700691$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cate, Emily W.</creatorcontrib><creatorcontrib>Rogers, John F.</creatorcontrib><creatorcontrib>Powell, J. Robert</creatorcontrib><title>Inhibition of Tolbutamide Elimination by Cimetidine but not Ranitidine</title><title>Journal of clinical pharmacology</title><addtitle>J Clin Pharmacol</addtitle><description>This study was designed to compare the effects of equivalent therapeutic doses of two H2 antagonists, cimetidine and ranitidine, on tolbutamide pharmacokinetics. Twelve healthy men were given a 1‐g oral dose of tolbutamide on three occasions. Subjects were randomly assigned to three treatments in a crossover fashion: cimetidine 1,200 mg/d, ranitidine 300 mg/d, and placebo. Cimetidine significantly increased the tolbutamide area under the plasma concentration‐time curve by 20% (range, −5% to 42%), increased the elimination half‐life by 17%, and decreased the carboxytolbutamide:tolbutamide plasma ratio from 0.042 to 0.036. Ranitidine did not significantly alter tolbutamide pharmacokinetics.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Blood Glucose - analysis</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Cimetidine - pharmacology</subject><subject>Double-Blind Method</subject><subject>Half-Life</subject><subject>Histamine and antagonists. Allergy</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Ranitidine - pharmacology</subject><subject>Tolbutamide - analogs & derivatives</subject><subject>Tolbutamide - blood</subject><subject>Tolbutamide - metabolism</subject><issn>0091-2700</issn><issn>1552-4604</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1986</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkM1O3DAUhS1EBVPaR0CKEGKX9N7YsRNWoIi_CihUIJaWndjCQ36GOKPOvH2TJpp9V7bu-e6x9RFyghAhQPxjGWGSxCHjwCLMUh71GmjCINrskcUu2icLgAzDWAAckq_eLwGQswQPyAEdZjzDBbm-a96ddr1rm6C1wUtb6XWvalea4KpytWvUv0hvg9zVpnela0wwIEHT9sFv1bhp9I18sary5vt8HpHX66uX_Da8_3Vzl1_ehwWjKYQ0RR2rmIO2LOZWlJpxUxRloUuh0PAEStCCGUyoziiYrFQWOWBqYxDUanpEzqbeVdd-ro3vZe18YapKNaZdeyl4Cog8HsDzCSy61vvOWLnqXK26rUSQo0S5lKMpOZqSo0Q5S5SbYfl4fmWta1PuVmdrQ34658oXqrKdagrnd5hI05QKNmAXE_bHVWb7Hx-QP_On2_E6VIRThfO92ewqVPchuaAikW-PN5I-CED6nEukfwFWF52N</recordid><startdate>198605</startdate><enddate>198605</enddate><creator>Cate, Emily W.</creator><creator>Rogers, John F.</creator><creator>Powell, J. Robert</creator><general>Blackwell Publishing Ltd</general><general>Sage Science</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198605</creationdate><title>Inhibition of Tolbutamide Elimination by Cimetidine but not Ranitidine</title><author>Cate, Emily W. ; Rogers, John F. ; Powell, J. Robert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4380-381b2a260bf426f7db46eccdcbd7a1e650d0b74e153b930e9daf16018f2073fb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1986</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Blood Glucose - analysis</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Cimetidine - pharmacology</topic><topic>Double-Blind Method</topic><topic>Half-Life</topic><topic>Histamine and antagonists. Allergy</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Ranitidine - pharmacology</topic><topic>Tolbutamide - analogs & derivatives</topic><topic>Tolbutamide - blood</topic><topic>Tolbutamide - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cate, Emily W.</creatorcontrib><creatorcontrib>Rogers, John F.</creatorcontrib><creatorcontrib>Powell, J. Robert</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cate, Emily W.</au><au>Rogers, John F.</au><au>Powell, J. Robert</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibition of Tolbutamide Elimination by Cimetidine but not Ranitidine</atitle><jtitle>Journal of clinical pharmacology</jtitle><addtitle>J Clin Pharmacol</addtitle><date>1986-05</date><risdate>1986</risdate><volume>26</volume><issue>5</issue><spage>372</spage><epage>377</epage><pages>372-377</pages><issn>0091-2700</issn><eissn>1552-4604</eissn><coden>JCPCBR</coden><abstract>This study was designed to compare the effects of equivalent therapeutic doses of two H2 antagonists, cimetidine and ranitidine, on tolbutamide pharmacokinetics. Twelve healthy men were given a 1‐g oral dose of tolbutamide on three occasions. Subjects were randomly assigned to three treatments in a crossover fashion: cimetidine 1,200 mg/d, ranitidine 300 mg/d, and placebo. Cimetidine significantly increased the tolbutamide area under the plasma concentration‐time curve by 20% (range, −5% to 42%), increased the elimination half‐life by 17%, and decreased the carboxytolbutamide:tolbutamide plasma ratio from 0.042 to 0.036. Ranitidine did not significantly alter tolbutamide pharmacokinetics.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>3700691</pmid><doi>10.1002/j.1552-4604.1986.tb03540.x</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0091-2700 |
ispartof | Journal of clinical pharmacology, 1986-05, Vol.26 (5), p.372-377 |
issn | 0091-2700 1552-4604 |
language | eng |
recordid | cdi_proquest_miscellaneous_76801162 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Adult Biological and medical sciences Blood Glucose - analysis Chromatography, High Pressure Liquid Cimetidine - pharmacology Double-Blind Method Half-Life Histamine and antagonists. Allergy Humans Male Medical sciences Pharmacology. Drug treatments Ranitidine - pharmacology Tolbutamide - analogs & derivatives Tolbutamide - blood Tolbutamide - metabolism |
title | Inhibition of Tolbutamide Elimination by Cimetidine but not Ranitidine |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T17%3A52%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibition%20of%20Tolbutamide%20Elimination%20by%20Cimetidine%20but%20not%20Ranitidine&rft.jtitle=Journal%20of%20clinical%20pharmacology&rft.au=Cate,%20Emily%20W.&rft.date=1986-05&rft.volume=26&rft.issue=5&rft.spage=372&rft.epage=377&rft.pages=372-377&rft.issn=0091-2700&rft.eissn=1552-4604&rft.coden=JCPCBR&rft_id=info:doi/10.1002/j.1552-4604.1986.tb03540.x&rft_dat=%3Cproquest_cross%3E76801162%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76801162&rft_id=info:pmid/3700691&rfr_iscdi=true |